[1] PEREIRA D, RAMOS E, BRANCO J.Osteoarthritis.Acta Med Port.2015;28(1):99-106.
[2] LI G, YIN J, GAO J, et al.Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes.Arthritis Res Ther.2013;15(6):223.
[3] MORITA Y, ITO H, ISHIKAWA M, et al.Subchondral bone fragility with meniscal tear accelerates and parathyroid hormone decelerates articular cartilage degeneration in rat osteoarthritis model.J Orthop Res.2018;36(7):1959-1968.
[4] SCOTECE M, CONDE J, ABELLA V, et al.Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways.Cell Physiol Biochem. 2018;49(6):2414-2426.
[5] HU N, GAO Y, JAYASURIYA CT, et al. Chondrogenic induction of human osteoarthritic cartilage-derived mesenchymal stem cells activates mineralization and hypertrophic and osteogenic gene expression through a mechanomiR.Arthritis Res Ther.2019;21(1):167.
[6] HALL AC.The Role of Chondrocyte Morphology and Volume in Controlling Phenotype-Implications for Osteoarthritis, Cartilage Repair, and Cartilage Engineering.Curr Rheumatol Rep.2019;21(8):38.
[7] SEIDL CI, MURPHY CL.Dual and Opposing Regulation of MMP1 and MMP13 by Both Arms of miR-675 in Human Articular Chondrocytes.Cell Physiol Biochem. 2019;53(1): 172-185.
[8] MURAOKA T, HAGINO H, OKANO T, et al.Role of subchondral bone in osteoarthritis development: a comparative study of two strains of guinea pigs with and without spontaneously occurring osteoarthritis.Arthritis Rheum. 2007;56(10):3366-3374.
[9] VAN SPIL WE, KUBASSOVA O, BOESEN M, et al. Osteoarthritis phenotypes and novel therapeutic targets. Biochem Pharmacol. 2019;165:41-48.
[10] 钟培瑞,廖瑛,廖源,等.去卵巢对大鼠膝关节软骨及软骨下骨的影响[J].风湿病与关节炎,2017,6(11):5-10,20.
[11] AHO OM, FINNILÄ M, THEVENOT J, et al. Subchondral bone histology and grading in osteoarthritis. PLoS One.2017;12(3): e0173726.
[12] IZAWA T, HUTAMI IR, TANAKA E.Potential Role of Rebamipide in Osteoclast Differentiation and Mandibular Condylar Cartilage Homeostasis.Curr Rheumatol Rev.2018; 14(1):62-69.
[13] JUNG YK, HAN MS, PARK HR, et al.Calcium-phosphate complex increased during subchondral bone remodeling affects earlystage osteoarthritis.Sci Rep.2018;8(1):487.
[14] ZHOU Y, MING J, LI Y, et al.Ligustilide attenuates nitric oxide-induced apoptosis in rat chondrocytes and cartilage degradation via inhibiting JNK and p38 MAPK pathways.J Cell Mol Med. 2019;23(5):3357-3368.
[15] LI WM, HAN CL, LIU C, et al.ANGPTL2 deletion inhibits osteoclast generation by modulating NF-κB/MAPKs/Cyclin pathways.Biochem Biophys Res Commun. 2018;503(3): 1471-1477.
[16] TSUKAMOTO M, MENUKI K, MURAI T, et al. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.Bone. 2016;85:70-80.
[17] BLANEY DEN, VAN CAAM AP, VAN DER KRAAN PM. Osteoarthritis year in review 2016: biology. Osteoarthritis Cartilage.2017;25(2):175-180.
[18] CHENG T, ZHANG L, FU X, et al.The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis.Connect Tissue Res. 2013; 54(2):139-146.
[19] KETOLA JH, KARHULA SS, FINNILÄ MAJ, et al. Iterative and discrete reconstruction in the evaluation of the rabbit model of osteoarthritis.Sci Rep.2018;8(1):12051.
[20] HØEGH-ANDERSEN P, TANKÓ LB, ANDERSEN TL, et al. Ovariectomized rats as a model of postmenopausal osteoarthritis: validation and application.Arthritis Res Ther. 2004;6(2):R169-180.
[21] KAMEKURA S, HOSHI K, SHIMOAKA T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability.Osteoarthritis Cartilage.2005;13(7): 632-641.
[22] KATAE Y, TANAKA S, SAKAI A, et al.Elcatonin injections suppress systemic bone resorption without affecting cortical bone regeneration after drill-hole injuries in mice.J Orthop Res. 2009;27(12):1652-1658.
[23] WALLACH S, ROUSSEAU G, MARTIN L, et al.Effects of calcitonin on animal and in vitro models of skeletal metabolism.Bone.1999;25(5):509-516.
[24] MIMPEN JY, SNELLING SJB.Chondroprotective Factors in Osteoarthritis: a Joint Affair.Curr Rheumatol Rep. 2019;21(8): 41.
[25] LI X, HE P, HOU Y, et al.Berberine inhibits the interleukin-1 beta-induced inflammatory response via MAPK downregulation in rat articular chondrocytes.Drug Dev Res. Drug Dev Res. 2019 Apr 29.
[26] WANG CJ, CHENG JH, CHOU WY, et al.Changes of articular cartilage and subchondral bone after extracorporeal shockwave therapy in osteoarthritis of the knee.Int J Med Sci. 2017;14(3):213-223.
[27] CHEN K, LV ZT, ZHOU CH, et al.Peimine suppresses interleukin‑1β‑induced inflammation via MAPK downregulation in chondrocytes.Int J Mol Med.2019;43(5): 2241-2251.
[28] PARK C, JEONG JW, LEE DS, et al.Sargassum serratifolium Extract Attenuates Interleukin-1β-Induced Oxidative Stress and Inflammatory Response in Chondrocytes by Suppressing the Activation of NF-κB,p38 MAPK,and PI3K/Akt.Int J Mol Sci.Int J Mol Sci. 2018;19(8). pii: E2308.
[29] ZHANG R, WANG CM, JIANG HJ, et al.Protective Effects of Sweroside on IL-1β-Induced Inflammation in Rat Articular Chondrocytes Through Suppression of NF-κB and mTORC1 Signaling Pathway.Inflammation. 2019;42(2):496-505.
[30] ELLIOTT SF, COON CI, HAYS E, et al.Bcl-3 is an interleukin-1-responsive gene in chondrocytes and synovial fibroblasts that activates transcription of the matrix metalloproteinase 1 gene. Arthritis Rheum. 2002;46(12): 3230-3239.
[31] VINCENT TL.IL-1 in osteoarthritis: time for a critical review of the literature.F1000Res. F1000Res. 2019;8. pii: F1000 Faculty Rev-934.
[32] HAN PF, WEI L, DUAN ZQ, et al.Contribution of IL-1β, 6 and TNF-α to the form of post-traumatic osteoarthritis induced by "idealized" anterior cruciate ligament reconstruction in a porcine model.Int Immunopharmacol.2018;65:212-220.
[33] CHE ATNA, LAU SF, MOHAMED S.Ficus deltoidea Prevented Bone Loss in Preclinical Osteoporosis/ Osteoarthritis Model by Suppressing Inflammation.Calcif Tissue Int. 2018;103(4):388-399.
[34] CHEN X, CHEN X, ZHOU Z, et al.Nirogacestat suppresses RANKL-Induced osteoclast formation in vitro and attenuates LPS-Induced bone resorption in vivo.Exp Cell Res. 2019;15: 111470.
[35] OK SM, LEE SM, PARK HR, et al.Concentrations of CTX I, CTX II, DPD, and PYD in the urine as a biomarker for the diagnosis of temporomandibular joint osteoarthritis: A preliminary study. Cranio. 2018;36(6):366-372.
[36] SHEN J, ABU-AMER Y, O'KEEFE RJ, et al.Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res. 2017;58(1):49-63.
[37] ISHIDA M, KITAURA H, KIMURA K, et al.Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.J Immunol Res.2015;2015:132765.
[38] ZHENG X, NIE Y, SUN C, et al.Long-term electroacupuncture stimulation prevents osteoporosis in ovariectomised osteopaenic rats through multiple signalling pathways. Acupunct Med. 2018;36(3):176-182.
[39] KARSDAL MA, HENRIKSEN K, ARNOLD M, et al. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs.2008;22(3):137-144.
[40] SHIBAKAWA A, YUDOH K, MASUKO-HONGO K, et al.The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthritis Cartilage. 2005;13(8):679-687.
[41] ZHANG LB, MAN ZT, LI W, et al.Calcitonin protects chondrocytes from lipopolysaccharide-induced apoptosis and inflammatory response through MAPK/Wnt/NF-κB pathways. Mol Immunol.2017;87:249-257.
[42] VLOT MC, DEN HEIJER M, DE JONGH RT, et al.Clinical utility of bone markers in various diseases. Bone.2018;114: 215-225.
[43] GLENDENNING P, CHUBB SAP, VASIKARAN S.Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.Clin Chim Acta. 2018;481:161-170.
|